Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986